Monitoring, legislative tracking and analysis run on their own.
You keep the human value-add.
The law puts an end to years of legal uncertainty over hydropower concessions - a major issue for operators and infrastructure funds.
Our agents pinpoint the decisive passages, produce a full analysis and brief you before you even ask.
The article introduces a new "additional contribution" that replaces the medicines safeguard clause as the regulatory mechanism.
Beyond a ceiling set each year, laboratories collectively pay a contribution to the national health insurer based on their revenue.
Since 2019, generic medicines have been subject to it despite their low prices and thin margins.
An adopted amendment seeks to exempt generics, hybrids and biosimilars - a sign that the issue is fiercely contested.
The safeguard clause, rebranded as an "additional contribution", makes laboratories pay back part of their sales beyond a ceiling. For generics, the bill now exceeds their own growth.
Beyond laws and amendments, the decisions of your regulators - CNIL, AMF, ARCEP, ADLC, ANSM, CRE - shape your framework, often quietly. We track them and translate them into concrete impact.
The CNIL authorises the Health Data Hub to process the health data of a sample of the French population, for 3 years, as part of the European DARWIN EU network.
Seized by advocacy groups, the Conseil d'État does not annul it: the authorisation applies only to data hosted in France and does not permit its transfer to the United States.
Some user data could technically transit via Microsoft, but the hosting contract provides for safeguards compliant with the GDPR.
No fine, no new law: just an administrative authorisation upheld by the court. But it sets the rules for accessing the health data of French citizens for medicines research.
Leave us your contact details and your use case. We'll come back to you with a demonstration on your own topics.